NEW YORK, NY / ACCESSWIRE / November 11, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Lipocine Inc. ("Lipocine" or the "Company") (LPCN) resulting from allegations that Lipocine might have issued misleading information to the investing public.

If you purchased Lipocine securities, and/or would like to discuss your legal rights and options please visit LPCN Shareholder Investigation or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

On November 11, 2019, Lipocine announced that it had received a Complete Response Letter ("CRL") from the U.S. Food and Drug Administration regarding its New Drug Application for TLANDO, Lipocine's product candidate for testosterone replacement therapy. Lipocine advised investors, among other things, that "[t]he CRL identified one deficiency stating the efficacy trial did not meet the three secondary endpoints for maximal testosterone concentrations." On this news, Lipocine's stock price fell sharply during trading on November 11, 2019.

If you purchased Lipocine securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/lipocineinc-lpcn-shareholder-class-action-lawsuit-stock-fraud-218/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:Matthew E. GuarneroBernstein Liebhard LLPhttp://www.bernlieb.com(877) 779-1414MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

View source version on accesswire.com: https://www.accesswire.com/566097/LPCN-LOSSES-ALERT-Bernstein-Liebhard-LLP-Reminds-Investors-of-Its-Investigation-of-Lipocine-Inc

Link:
LPCN LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of Its Investigation of Lipocine Inc - Yahoo Finance